Sunridge International (OTC Bulletin Board: SNDZ) announced today that they have extended the exclusive distribution agreement with Beijing Vision World Trading Co., Ltd. for an additional 4 years.
"I am very happy to sign this agreement," states G. Richard Smith, CEO of Sunridge International (www.sunridgeint.com). "We have worked closely with Beijing Vision World Trading Co., Ltd. (BV) over the last 3 1/2 years to complete the registration process for Pneumatic Trabeculoplasty, 'PNT' in China."
PNT is a two-minute, noninvasive, cost effective, alternative treatment for glaucoma and ocular hypertension, which was developed and patented by Ophthalmic International (www.oi-pnt.com), Sunridge Internationals wholly owned subsidiary.